Rafferty Asset Management
CTXR icon

Rafferty Asset Management’s Citius Pharmaceuticals CTXR Stock Holding History

Rafferty Asset Management’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,010
Closed -$46K – 1167
2022
Q2 		$46K Sell
2,010
-86
-4% -$1.97K ﹤0.01% 1106
2022
Q1 		$94K Sell
2,096
-13
-0.6% -$583 ﹤0.01% 1175
2021
Q4 		$81K Buy
2,109
+84
+4% +$3.23K ﹤0.01% 1267
2021
Q3 		$103K Buy
+2,025
New +$103K ﹤0.01% 1222